Search

4 July 2022 - Hear from Dr Lucas de Toca PSM on COVID-19 oral treatments, how the various medicines differ from each other, and who is eligible to receive them.

2 June 2025 - Information about the whooping cough vaccine, who they are recommended for and possible side effects. If you're eligible, you can get the whooping cough vaccine for free under the National Immunisation Program.

11 June 2025 - If you work in allied health or primary care, or have an interest in the allied health care sector, subscribe to our allied health sector updates to keep informed about our program of work and relevant allied health news.

19 September 2025 - This collection contains fact sheets, frequently asked questions and flowcharts about the Medicare services available for complex neurodevelopmental conditions and eligible disabilities

31 March 2026 - The 2026 Senior Australian of the Year state and territory recipients share common misunderstandings about older people and share simple ways to stay active, involved and connected.

2 April 2025 - Tackling Antimicrobial Resistance in Aged Care Facilities has been consolidated into the Global Health initiative under the MRFF 10-year Investment Plan. This initiative helped tackle the threat of microbes such as bacteria, viruses or parasites becoming resistant to standard medical treatments.

10 September 2025 - Christine Edwards is a consumer advocate dedicated to shaping health research through lived experience, so it has meaningful, real-world outcomes. She recently shared her thoughts about the valuable role of consumers and the Medical Research Future Fund (MRFF) as part of our 10-year celebrations.

4 November 2025 - If you are an Aboriginal or Torres Strait Islander person aged 50 or over, you may be eligible for aged care. You can apply for an aged care assessment to see what support is available.

23 June 2020 - The Medical Research Future Fund is providing $35.9 million for 17 cutting-edge research projects. The projects are designed to improve the diagnosis and treatment of cancer, improve neonatal outcomes and prevent bone loss in critically ill women.

17 June 2025 - This 24 month-like review aimed to ensure that the listing of elosulfase alfa for the treatment of MPS IVA on the LSDP remains appropriate. It was considered by the Expert Panel at its October 2022 and February 2023 meetings.